Clinical trial
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
NCT00633776
Study timeline
Study start (unknown)2008-03-01Date precision: month
Registry last updated2016-08-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Obstructive Pulmonary Diseaseunresolved
COPDunresolved
Chronic Bronchitisunresolved
Emphysemaunresolved
Interventions
formoterol fumarateDRUG · verified · RxNorm: formoterol fumarate
Sponsors & collaborators
University of California, Los Angeleslead sponsor
Dey, L.P.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00633776 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.